A multicentre randomised double-blind placebo-controlled phase II study of celecoxib and concurrent radiotherapy in stage II-III NSCLC [non-small cell lung cancer]. An evaluation of both tumor radiosensitization and normal tissue protection

Trial Profile

A multicentre randomised double-blind placebo-controlled phase II study of celecoxib and concurrent radiotherapy in stage II-III NSCLC [non-small cell lung cancer]. An evaluation of both tumor radiosensitization and normal tissue protection

Completed
Phase of Trial: Phase II

Latest Information Update: 28 May 2008

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 May 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov.
    • 01 Jul 2007 Results have been reported
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top